Regulatory & Legal

After a year away, ENGWE is back in the U.S. with a beastly new e-bike. Can the M20 3.0's monster specs overcome past issues and a crowded market?

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

A new PropTech startup is using a memorable phone number and advanced AI to bypass Zillow, promising cheaper, more accurate home valuations for everyone.

Following key permitting wins, Integra Resources' oversubscribed $61.6M financing signals strong investor faith and accelerates its DeLamar gold project.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

Bunker Hill Mining bets big with a C$30M capital raise and a drastic 1-for-35 reverse stock split, aiming for NYSE and full mine production.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

As new EU laws on AI and sustainability take full effect, over 250 compliance leaders will meet in Berlin to forge strategies for navigating the risks.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

NOVAGOLD and Paulson select engineering leader Fluor for a key study, pushing the massive Donlin Gold project in Alaska closer to development and financing.

A new technical report reveals an 85% IRR for the Arraias project, positioning Itafos to tap into Brazil's huge domestic fertilizer market.

New drill results from Emerita's El Cura deposit show significant high-grade metals, boosting a key study and Europe's critical mineral supply chain.

Heart disease is the leading cause of premature death for Canadian women, yet it remains under-diagnosed and under-treated. A national movement is fighting back.

With a new CEO from Visa-acquired Featurespace and fresh private equity backing, Ripjar is escalating its AI-driven battle against global financial crime.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

A new subcutaneous autoinjector for Alzheimer's drug Leqembi could soon transform care for millions in China, moving treatment from hospital to home.

Key Mining Corp. is going public via a SPAC deal to fund a massive titanium project in Chile, betting on rising demand for critical minerals.